中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
10期
1914-1916
,共3页
倪侃%陈佳慧%贾乃昕%吴龙祥%常仁安%陈钟
倪侃%陳佳慧%賈迺昕%吳龍祥%常仁安%陳鐘
예간%진가혜%가내흔%오룡상%상인안%진종
癌,肝细胞%polo样激酶-1%小干扰RNA
癌,肝細胞%polo樣激酶-1%小榦擾RNA
암,간세포%polo양격매-1%소간우RNA
Carcinoma,hepatocellular%Polo-like kinase-1%Small interfering RNA
目的 构建polo样激酶-1(PLK1)基因小干扰RNA(siRNA),观察其对肝癌细胞凋亡的影响.方法 设计合成3个PLK1 siRNA(siRNA1、siRNA2、siRNA3)干扰序列,构建干扰载体,转染人肝癌细胞株SMMC-7721,观察48 h后转染效率,采用实时定量逆转录-聚合酶链反应(RT-PCR)筛选下调PLK1 mRNA效果最好的siRNA;然后选择以该siRNA转染48 h的SMMC-7721细胞,分别以实时定量RT-PCR和Western blot法检测空白组、对照组及转染组细胞中PLK1基因和蛋白表达;流式细胞仪检测细胞周期及细胞凋亡的改变.结果 肝癌细胞株SMMC-7721中存在PLK1蛋白的过表达.应用靶向PLK1的siRNA转染SMMC-7721细胞48 h后,PLK1 mRNA相对水平siRNA2组分别较无关对照组和空白对照组下降了74%和78%,而PLK1蛋白的表达siRNA2组分别较无关对照组和空白对照组下降了83%和88%,抑制率达88%;siRNA2组中出现大量凋亡细胞,与对照组比较差异有统计学意义(P< 0.05).结论 PLK1基因在肝癌细胞增殖中具有重要的调控作用.PLK1-siRNA转染可明显抑制癌细胞增殖,诱导凋亡是其重要机制之一.
目的 構建polo樣激酶-1(PLK1)基因小榦擾RNA(siRNA),觀察其對肝癌細胞凋亡的影響.方法 設計閤成3箇PLK1 siRNA(siRNA1、siRNA2、siRNA3)榦擾序列,構建榦擾載體,轉染人肝癌細胞株SMMC-7721,觀察48 h後轉染效率,採用實時定量逆轉錄-聚閤酶鏈反應(RT-PCR)篩選下調PLK1 mRNA效果最好的siRNA;然後選擇以該siRNA轉染48 h的SMMC-7721細胞,分彆以實時定量RT-PCR和Western blot法檢測空白組、對照組及轉染組細胞中PLK1基因和蛋白錶達;流式細胞儀檢測細胞週期及細胞凋亡的改變.結果 肝癌細胞株SMMC-7721中存在PLK1蛋白的過錶達.應用靶嚮PLK1的siRNA轉染SMMC-7721細胞48 h後,PLK1 mRNA相對水平siRNA2組分彆較無關對照組和空白對照組下降瞭74%和78%,而PLK1蛋白的錶達siRNA2組分彆較無關對照組和空白對照組下降瞭83%和88%,抑製率達88%;siRNA2組中齣現大量凋亡細胞,與對照組比較差異有統計學意義(P< 0.05).結論 PLK1基因在肝癌細胞增殖中具有重要的調控作用.PLK1-siRNA轉染可明顯抑製癌細胞增殖,誘導凋亡是其重要機製之一.
목적 구건polo양격매-1(PLK1)기인소간우RNA(siRNA),관찰기대간암세포조망적영향.방법 설계합성3개PLK1 siRNA(siRNA1、siRNA2、siRNA3)간우서렬,구건간우재체,전염인간암세포주SMMC-7721,관찰48 h후전염효솔,채용실시정량역전록-취합매련반응(RT-PCR)사선하조PLK1 mRNA효과최호적siRNA;연후선택이해siRNA전염48 h적SMMC-7721세포,분별이실시정량RT-PCR화Western blot법검측공백조、대조조급전염조세포중PLK1기인화단백표체;류식세포의검측세포주기급세포조망적개변.결과 간암세포주SMMC-7721중존재PLK1단백적과표체.응용파향PLK1적siRNA전염SMMC-7721세포48 h후,PLK1 mRNA상대수평siRNA2조분별교무관대조조화공백대조조하강료74%화78%,이PLK1단백적표체siRNA2조분별교무관대조조화공백대조조하강료83%화88%,억제솔체88%;siRNA2조중출현대량조망세포,여대조조비교차이유통계학의의(P< 0.05).결론 PLK1기인재간암세포증식중구유중요적조공작용.PLK1-siRNA전염가명현억제암세포증식,유도조망시기중요궤제지일.
Objective To study effects of polo-like kinase-1 (PLK1) small interfering RNA (siRNA) on proliferation of human hepatocellular carcinoma (HCC) cells.Methods Three PLK1 siRNAs (siRNA1,siRNA2,siRNA3) were constructed and use to transfect SMMC-7721 cells.Transfection efficiency at 48 h was observed.Real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to find the most effective siRNA which was then used to transfect SMMC-7721 cells.RT-PCR and Western blotting were used to detect PLK1 expression in SMMC-7721 cells which were divided into different groups.Flow cytometry (FCM) was used to detect apoptosis rate and phase distribution of cell cycles.Results PLK1 protein was overexpressed in SMMC-7721 cells.SMMC-7721 cells transfected with low doses of siRNAs targeted against PLK1 had greatly decreased levels of PLK1 mRNA and protein.Compared to blank control and negative control 48 h after transfection,siRNA2 reduced PLK1 mRNA by 74% and 78%,and PLK1 protein by 83% and 88%,respectively.Apoptosis rate was increased remarkably and the phenotypes of apoptosis could be seen in transfected cells 48 h after transfection.Conclusion PLK1 may play an important role in proliferation of HCC cells.PLK1 siRNA transfection can inhibit proliferation of HCC cells through apoptosis induction.